Activation of spleen lymphocytes by plasmid DNA

Vaccine. 1999 Mar 5;17(9-10):1193-200. doi: 10.1016/s0264-410x(98)00340-5.

Abstract

Plasmid pUC19 DNA was shown to stimulate in vitro proliferation of CBA mouse splenocytes in a dose-dependent manner. Simultaneous treatment of the cells with the plasmid DNA and Con A or LPS produced an additive effect, while PMA acted synergistically with DNA. Monovalent Fab fragments of rabbit anti-mouse Ig (RAMIg) antibodies significantly inhibited plasmid DNA-induced polyclonal lymphocyte activation suggesting the involvement of Ig receptors in this process. Affinity modification of lymphocytes membrane-cytosole proteins with a 32P-labeled alkylating oligonucleotide derivative resulted in labeling of 67-82 and 23 kDa polypeptides corresponding to IgD and IgM heavy and light chains respectively. The immunoglobulin nature of the 82 and 23 kDa oligonucleotide-binding polypeptides was confirmed by immunoprecipitation with RAMIg antibodies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Division / drug effects
  • DNA / pharmacology*
  • DNA-Binding Proteins / metabolism
  • Immunoglobulin Fab Fragments / pharmacology
  • Immunoglobulin Fragments / pharmacology
  • Lymphocyte Activation* / drug effects
  • Lymphocytes / drug effects*
  • Lymphocytes / immunology
  • Mice
  • Plasmids / genetics*
  • Rabbits
  • Receptors, Immunologic / immunology
  • Spleen / cytology
  • Spleen / drug effects*
  • Spleen / immunology

Substances

  • DNA-Binding Proteins
  • Immunoglobulin Fab Fragments
  • Immunoglobulin Fragments
  • Receptors, Immunologic
  • DNA